ICON PLC
NASDAQ:ICLR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
187.22
346.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
ICON PLC
ICON PLC
Income from Continuing Operations
ICON PLC
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
ICON PLC
NASDAQ:ICLR
|
Income from Continuing Operations
$747.9m
|
CAGR 3-Years
61%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
|
M
|
Malin Corporation PLC
ISEQ:MLC
|
Income from Continuing Operations
-€1.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
ICON PLC
Glance View
ICON PLC, a leading global provider of outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries, has carved a niche for itself in the critical world of clinical research. Founded in 1990 and headquartered in Dublin, Ireland, ICON PLC combines innovative technologies with deep industry expertise to assist clients at every stage of their product development journey. As the demand for faster and more efficient drug development grows, ICON's comprehensive service offerings—including clinical trial management, analytics, and regulatory consulting—position the company as a vital partner for organizations aiming to bring new therapies to market. With a keen focus on improving patient outcomes and ensuring high-quality results, ICON has built a reputation for operational excellence and customer satisfaction. For investors, ICON PLC represents a compelling opportunity in the booming healthcare sector. Its robust financial performance, characterized by consistent revenue growth and healthy profit margins, reflects its capacity to adapt to the evolving landscape of clinical research. Moreover, the company’s strategic acquisitions and investments in cutting-edge technology underscore its commitment to remaining at the forefront of industry advancements. As ICON continues to expand its global footprint and leverage its extensive expertise, it stands to benefit from the rising demand for clinical services and the increasing complexity of modern drug development. With a strong management team and a clear vision for the future, ICON PLC is well-positioned to deliver sustainable value to its shareholders.
See Also
What is ICON PLC's Income from Continuing Operations?
Income from Continuing Operations
747.9m
USD
Based on the financial report for Sep 30, 2024, ICON PLC's Income from Continuing Operations amounts to 747.9m USD.
What is ICON PLC's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
17%
Over the last year, the Income from Continuing Operations growth was 45%. The average annual Income from Continuing Operations growth rates for ICON PLC have been 61% over the past three years , 15% over the past five years , and 17% over the past ten years .
You don't have any saved screeners yet
